Exploring Africa HIV Drugs Market: Rising Trends, Opportunities and Challenges Forecast 2030
MarkNtel Advisors recently published a detailed industry
analysis of the Africa HIV Drugs Market. The report covers growth
trends, regional marketing strategies, challenges, opportunities, and drivers
influencing the market
The Africa HIV Drugs Market size is estimated to grow at a
CAGR of around 8.20% during the forecast period, i.e., 2024-30.
Global Africa HIV
Drugs Market Driver:
Africa HIV Drugs
Market Driver:
The High Rate of HIV in African Girls & Women – The
epidemiological evidence suggests that the prevalence and rates of HIV are
unacceptably high among women in Africa. For instance,
As per the Joint United Nations Programme, in 2022,
adolescent girls and young women accounted for more than 77% of new infections
among young people aged 15-24 years in sub-Saharan Africa.
The UNAIDS data also highlighted that every week, 3100
adolescent girls and young women aged 15–24 years became infected with HIV in
sub-Saharan Africa in 2022.
The combination of several factors, including biological,
social, behavioral, cultural, economic, and structural, in sub-Saharan Africa
has led to a disparate increase in HIV infection rates among women compared to
their male counterparts. Thus, the rising HIV cases further necessitate that
the young girls and women in the region go for proper diagnosis and treatment
for HIV to avoid adverse consequences. This has been primarily because the
treatment in the form of HIV drugs belonging to different classes, such as
nucleoside reverse transcriptase inhibitors (NRTIs), integrase inhibitors,
protease inhibitors, etc., not only allows these women with HIV to live longer,
healthier lives but also reduces the risk of further HIV transmission.
Moreover, the rising awareness among African women regarding
the effects of HIV drugs and their willingness to live longer and healthier
lives would further augment the size & volume of the Africa HIV Drugs
Market in the coming years.
Access the detailed
PDF Sample report – https://www.marknteladvisors.com/query/request-sample/africa-hiv-drugs-market.html
What segments define
the Africa HIV Drugs market from 2024- 2030? How do these segments contribute
to market dynamics and growth?
-By Drug Class
-Nucleoside Reverse Transcriptase Inhibitors (NRTIs)- Market
Size & Forecast 2019-2030, USD Million
-Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)-
Market Size & Forecast 2019-2030, USD Million
-Protease Inhibitors- Market Size & Forecast 2019-2030,
USD Million
-Integrase Inhibitors- Market Size & Forecast 2019-2030,
USD Million
-Fusion Inhibitors-Vector- Market Size & Forecast
2019-2030, USD Million
-Coreceptor Antagonists- Market Size & Forecast
2019-2030, USD Million
-Combination HIV Drugs- Market Size & Forecast
2019-2030, USD Million
-Others (Pharmacokinetic Enhancers, Capsid Inhibitors,
etc.)- Market Size & Forecast 2019-2030, USD Million
-By Route of Administration
-Oral Drugs- Market Size & Forecast 2019-2030, USD
Million
-Injectable Drugs- Market Size & Forecast 2019-2030, USD
Million
-By Distribution Channel
-Hospital Pharmacies - Market Size & Forecast 2019-2030,
USD Million
-Retail Pharmacies- Market Size & Forecast 2019-2030,
USD Million
-Online Pharmacies- Market Size & Forecast 2019-2030,
USD Million
Explore the Complete Africa HIV Drugs Market Analysis Report –https://www.marknteladvisors.com/research-library/africa-hiv-drugs-market.html
-By Country
-South Africa
-Algeria
-Nigeria
-Kenya
-Uganda
-Rest of Africa
Who are the leading
key players shaping the Africa HIV Drugs Market landscape?
Aurobindo Pharma, ViiV Healthcare group of companies,
Johnson & Johnson Services, Inc., Merck & Co., Inc., Cipla Inc.,
Bristol-Myers Squibb Company, AbbVie Inc., Gilead Sciences, Inc., Aspen
Holdings, Cosmos Limited, and others
Questions Addressed
in this Study
1.What factors are driving the Africa HIV Drugs Market
growth?
2.What are the key insights into the current trends in the Africa
HIV Drugs Market Market?
3.What is the current size of the Africa HIV Drugs Market,
and how is it projected to change in the future?
4.What is the future outlook for the Africa HIV Drugs Market
in terms of technological advancements and market expansion?
For a Customized
Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/africa-hiv-drugs-market.html
“Market research studies from MarkNtel
Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of
the payment being successfully received, the report will be sent to your email
address.”
Why MarkNtel
Advisors?
MarkNtel Advisors is a leading research, consulting, &
data analytics firm that provides an extensive range of strategic reports on
diverse industry verticals. We deliver data to a substantial & varied
client base, including multinational corporations, financial institutions,
governments, & individuals, among others.
Our specialization in niche industries & emerging
geographies allows our clients to formulate their strategies in a much more
informed way and entail parameters like Go-to-Market (GTM), product
development, feasibility analysis, project scoping, market segmentation,
competitive benchmarking, market sizing & forecasting, & trend analysis,
among others, for 15 diverse industrial verticals.
For Media Inquiries,
Please Contact:
Call: +1 628 895
8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564
Prospect St, B9, New Haven, Connecticut, USA-06511
Comments
Post a Comment